Price movement over the last 24 hours
Agilent Technologies Inc vs PepsiCo, Inc. — how do they compare? Agilent Technologies Inc trades at $128.2 (market cap $37.04B), while PepsiCo, Inc. trades at $144.02 (market cap $198.15B). The key difference: PepsiCo, Inc. is far larger — about 5.3× Agilent Technologies Inc's market cap, and PepsiCo, Inc. pays the higher dividend (4.08%). Which is the better fit depends on your goals.
| A | PEP | |
|---|---|---|
Market Cap | $37.04B | $198.15B |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $170.44 |
52-Week Low | $110.24 | $133.81 |
Enterprise Value | $38.59B | $240.05B |
Dividend Yield | 0.78% | 4.08% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
PepsiCo (PEP) trades at $144.6, up 0.91% on the day, with a bullish technical signal and recent earnings beats. The stock shows strong profitability with a 9.15% net margin and 43.92% ROE, though revenue growth remains modest at 2.2% year-over-year. Recent news highlights price cuts on snacks after consumer pushback on high prices, while the company prepares for Q1 2026 earnings next week.
The outlook is cautiously optimistic with a consensus price target of $161.73 (12% upside). Analyst sentiment leans neutral (63.64% Hold), balancing strong cash flow and brand power against pricing pressures and modest growth. Key risks include execution of North America turnaround and consumer sensitivity to price hikes.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →